Clinical trial
Infliximab Top-down Study in Kids With Crohn's Disease
NCT01880307 is registered in ClinicalTrials.gov with Erasmus Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Infliximab Top-down Study in Kids With Crohn's Disease
- Lead sponsor
- Erasmus Medical Center
- Phase
- Phase 4
- Overall status
- Terminated
- Start date
- January 31, 2013
- Completion date
- Not reported
- Enrollment
- 13 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
crohn's disease